- Home
- GORV vs ABVC Comparison
GORV vs ABVC Comparison
Compare GORV & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- ABVC
- Stock Information
- Founded
- GORV 1976
- ABVC 2015
- Country
- GORV United States
- ABVC United States
- Employees
- GORV N/A
- ABVC N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- ABVC Health Care
- Exchange
- GORV Nasdaq
- ABVC Nasdaq
- Market Cap
- GORV 22.6M
- ABVC 18.8M
- IPO Year
- GORV 2015
- ABVC N/A
- Fundamental
- Price
- GORV $0.16
- ABVC $1.46
- Analyst Decision
- GORV Hold
- ABVC
- Analyst Count
- GORV 2
- ABVC 0
- Target Price
- GORV $2.00
- ABVC N/A
- AVG Volume (30 Days)
- GORV 261.8K
- ABVC 248.3K
- Earning Date
- GORV 05-15-2025
- ABVC 04-30-2025
- Dividend Yield
- GORV N/A
- ABVC N/A
- EPS Growth
- GORV N/A
- ABVC N/A
- EPS
- GORV N/A
- ABVC N/A
- Revenue
- GORV $871,562,000.00
- ABVC $508,383.00
- Revenue This Year
- GORV $15.65
- ABVC $735.18
- Revenue Next Year
- GORV $20.54
- ABVC N/A
- P/E Ratio
- GORV N/A
- ABVC N/A
- Revenue Growth
- GORV N/A
- ABVC 1904.43
- 52 Week Low
- GORV $0.20
- ABVC $0.40
- 52 Week High
- GORV $4.00
- ABVC $1.40
- Technical
- Relative Strength Index (RSI)
- GORV 30.45
- ABVC 64.11
- Support Level
- GORV $0.14
- ABVC $1.18
- Resistance Level
- GORV $0.22
- ABVC $1.36
- Average True Range (ATR)
- GORV 0.03
- ABVC 0.14
- MACD
- GORV 0.01
- ABVC 0.05
- Stochastic Oscillator
- GORV 13.64
- ABVC 63.74
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.